Abstract
Adaptive aberrant gene regulation is a hallmark of malignant growth and therapy resistance in acute myeloid leukemia (AML). In this issue of Cell Stem Cell, Eagle et al. identified oncogenic enhancer-driven overexpression of selenophosphate synthetase 2 (SEPHS2) as an opportunity for targeted mitigation of malignant cell growth in AML.
Original language | English (US) |
---|---|
Pages (from-to) | 350-352 |
Number of pages | 3 |
Journal | Cell Stem Cell |
Volume | 29 |
Issue number | 3 |
DOIs |
|
State | Published - Mar 3 2022 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology